Sage Journals: Discover world-class research

Abstract

Background:

Albumin is important for the transport of protein-bound substances (PBS). Albumin binding capacity (ABiC) is reduced in dialysis patients. This can contribute to worsening of uremic symptoms. It is presumed that open-porous middle cut off filters that is, HDx (Baxter-Theranova) remove high molecular substances more efficiently than conventional treatment. To evaluate HDx for the improvement of ABiC and removal of PBS, HDx was compared to hemodiafiltration (Fresenius-FX80, HDF).

Methods:

We included 32 chronic patients on HDF. After inclusion patients were treated with HDx for 14 days. Blood samples were drawn before/after treatments at study entry, first HDx and sixth HDx, to determine ABiC and other study parameters.

Results:

ABiC improved in HDx (68.4% vs 72.4%) and HDF (69.9% vs 72.4%) without differences between both therapies. No reduction of albumin concentration during HDx treatment was observed.

Conclusion:

HDx is accepted as a safe and equally efficient therapy for removing albumin bound uremic toxins compared to HDF with high flux dialyzers.

Keywords

Middle cut off dialyzers uremic toxins albumin bound toxins HDx extended dialysis hemodiafiltration

Get full access to this article

View all access options for this article.

References

Duranton

Cohen

De Smet

, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012; 23(7): 1258–1270.

Klammt

Brinkmann

Mitzner

, et al. Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers. Z Gastroenterol. 2001; 39(Suppl. 2): 24–27.

Klammt

Mitzner

Stange

, et al. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl 2008; 14(9): 1333–1339.

Maduell

Rodas

Broseta

, et al. High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration. Artif Organs 2019; 43: 1014–1021.

Belmouaz

Diolez

Bauwens

, et al. Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules. Clin Nephrol 2018; 89(1): 50–56.

Ronco

The rise of expanded hemodialysis. Blood Purif 2017; 44(2): I–VIII.

Klammt

Mitzner

Stange

, et al. Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease. Eur J Gastroenterol Hepatol 2007; 19(3): 257–263.

Klammt

Wojak

Mitzner

, et al. Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins. Nephrol Dial Transplant 2012; 27(6): 2377–2383.

Mitzner

Klammt

Koball

, et al. Albumin-dialysis but not conventional hemodialysis increases the reduced albumin-binding capacity in end-stage renal failure. Nephrol Dial Transplant 2006; 27(6): 477–478.

10.

Ronco

Marchionna

Brendolan

, et al. Expanded haemodialysis: from operational mechanism to clinical results. Nephrol Dial Transplant 2018; 33(Suppl. 3): iii41–iii47.

Comparison of changes in albumin binding capacity during hemodiafiltration or hemodialysis with middle cut off membranes

Abstract

Background:

Methods:

Results:

Conclusion:

Keywords

Get full access to this article

References